AKT1 and non-small cell lung carcinoma: Abnormal activation of the MAPK [11,12], PI3K/AKT/mTOR [13,14,15], and Wnt [16,17] pathways is frequently observed in NSCLC, and the activation of these pathways promotes the progression, drug resistance, proliferation, migration, and invasion of NSCLC.